GliGene debuts to focus on hedgehog pathway

Newco GliGene AB (Solna, Sweden) raised SEK6.8 million ($1 million) from the KDev Oncology AB subsidiary of Karolinksa Development AB (SSE:KDEV). GliGene is developing small molecular antagonists of t...